investment strategies – The Investment Journal

The US consumer is the bedrock of our economy.

If that’s truly the case — (and it is) — then signals are flashing everywhere that the economy is headed for trouble.

Case in point…

The Tylers over at ZeroHedge reported:

Bloomberg Intelligence’s Joel Levington published a new report Monday, citing new data from CarEdge that showed a staggering 39% of vehicles financed since 2022 carry negative equity, including 46% of EVs…

What this basically means is that balances on people’s auto loans are more than the value of the vehicle they’re paying on.

Now falling car values shouldn’t come as a surprise to anyone.

A car is not an asset in any “investment” sense of the word. It’s a means of transportation.

In the world of business, vehicles are recognized as “depreciating assets” (over the “useful life” of the vehicle) on a business’ taxes. They have a tax-reducing effect on their bottom line.

Depreciation refers to the decrease in value of long-term assets over time. Depreciation is spread over the useful life of the asset and is intended to realistically reflect the actual value of the asset and the profit. Furthermore, it is designed to have a tax-reducing effect. Depreciation of vehicles is done on a linear basis, meaning the vehicle’s value is evenly spread over its useful life. The vehicle’s useful life plays a crucial role in this process. The amount of depreciation depends on the purchase price and the vehicle’s useful life.

There’s a maxim that says cars depreciate by over 10% the minute you drive it off the dealer’s lot. So you’re pretty much starting in the hole.

So, again, the fact that the value of American’s cars are falling shouldn’t be any surprise. What is troubling is the fact that consumers still owe so much on their vehicles.

Consumers Are Sinking Fast

The Federal Reserve just reported that the average finance charge for a new car in Q3 2024 was 8.76%! But that’s not the really shocking part. What really catches your attention is that’s the rate being charged for a 72 month loan!

Six years to pay off a car? Not long ago four years was pretty much the financing limit.

The problem stems from a combination of factors.

Back during the pandemic stimulus spree, the extra free money (not to mention the near zero financing cost) at the time made trading in the old car seem like a good idea.

The stampede to the local car dealer (along with the supply fiasco) drove new car prices through the roof.

Source: Federal Reserve Bank of St. Louis

After some 20-plus years of relative price stability in the new car market, prices exploded by over 20% in a span of three years thanks to all the “free” money.

Today, thanks to the sharply higher prices, auto loan balances rose by $18 billion in the last quarter alone, and now stand at $1.64 trillion — the highest category of non-housing debt.

These unaffordable prices are what’s behind the longer and longer financing terms.

Further according to Experian 33% of monthly car payments stand between $500-$700 per month. And, hold on to your hats, over 16% are over $1,000.

This would be fine if everyone could afford it. But 90-plus day delinquency rates on auto loans just upticked again to 4.6%. (Which might not seem bad compared to credit card delinquencies which have reached 11.1%!)

There’s an idea floating around that the economy is doing just fine.

But when you look past the headlines (and you don’t have to look far) you can see the strains building.

It’s a legacy that’ll likely end up being studied in grad school business books for years to come.

But whether it’s a story of success or failure remains to be seen.

In its 50-plus year history, Intel has gone from the world’s dominant semiconductor chip producer to verging on the edge of failure.

Not necessarily a reputation you like to hang your hat on.

In our last post, we said the government tends to make bad decisions when it comes to ~~spending~~ investing your money. Early this year, Intel put in and received the promise of a big chunk of Chips Act money to help build new fabrication and research facilities in Arizona.

If only $20 billion were the solution to all Intel’s problems.

The Big Arizona Bet

By way of a little background, Intel has committed to building two state-of-the-art fabrication plants (known as “fabs”) in Chandler, Arizona that will employ the company’s latest chipmaking process known as “18A.”

That number describes a 1.8 nanometer-class chip that would effectively compete with the 2nm and 3nm chips currently produced by Taiwan Semiconductor Manufacturing (TSM) — the world’s biggest contract fab.

Intel’s plan is to further compete with the likes of TSM by splitting their business into design-side and the manufacturing-side entities. CEO Pat Gelsinger explained In a recent company memo:

A subsidiary structure will unlock important benefits. It provides our external foundry customers and suppliers with clearer separation and independence from the rest of Intel. Importantly, it also gives us future flexibility to evaluate independent sources of funding and optimize the capital structure of each business to maximize growth and shareholder value creation.

Some prospective customers have taken note.

Amazon Web Services recently cut a deal with Intel to co-invest in a custom chip design based on the 18A platform for its servers. The deal was “a multi-year, multi-billion-dollar framework,” according to the press release.

On paper, this all sounds like a step in the right direction. Except the road ahead is anything but smooth. Fortune recently reported:

Meanwhile, costs for Intel’s planned Arizona fabs and two more in Ohio have soared past initial projections. The Arizona plants, which Intel is counting on having online in 2025, have been hit by construction delays.

Which has impacted the availability of $20 billion from the Chips Act:

In March it was awarded $8.5 billion in direct CHIPS funding and $11 billion in loans. But the money is tied to Intel hitting certain construction milestones, and it has yet to receive any funds.

And if that wasn’t enough…

And in September, Reuters reported that Broadcom, which makes networking and radio chips, had tested Intel’s process and concluded it was not yet ready for full production.

According to the WSJ: “Intel’s manufacturing arm is money-losing and hasn’t gained strong traction with customers other than Intel itself since Gelsinger opened the factories to outside chip designers three years ago.”

Completing the business split and getting the new fabs into production are critical for Intel’s future success.

White Knights to the Rescue?

Just two weeks ago, rival chip manufacturer Qualcomm approached Intel to discuss a possible takeover.

Intel’s stock popped. Qualcomm’s took a hit.

That’s because the deal would be a major financial stretch for QCOM.

The deal would be valued significantly above the amount of cash Qualcomm has on its balance sheet and would require taking on significant debt or diluting the company’s shareholders. This deal is viewed as a longshot at best.

Not long after the Qualcomm news broke, Apollo Global Management approached Intel with another offer to support their turnaround efforts:

Bloomberg reported, citing sources familiar with the matter, that Apollo recently proposed an equity-like investment of up to $5 billion to Intel’s management. The people said Intel execs were mulling over the proposal. There were no definite, as the investment could change or fall apart.

And there’s more good news coming from the government…

The Biden-Harris Administration announced today that Intel Corporation has been awarded up to $3 billion in direct funding under the CHIPS and Science Act for the Secure Enclave program. The program is designed to expand the trusted manufacturing of leading-edge semiconductors for the U.S. government.

This is a DoD targeted program that’s separate from the other $20 billion that’s stuck in limbo.

Can They Be the Comeback Kids?

Intel has a history of being on the wrong side of industry trends. (Like when it opted not to provide Apple with chips for its iPhone and ignored its GPU division as Nvidia was making inroads into the AI trend.)

Yet there’s always hope to right the ship.

Meta managed to do it — with a disciplined program of slashing costs and refocusing on its core business — after a disastrous investment in the metaverse that cost them three-quarters of their market cap in a little over a year.

But can Intel?

Given their history in the chip business, they’ll certainly be a stock to watch…

Is the end of AI at hand?

For the past several years, tech heavyweights have been pouring billions into AI development. According to CNBC:

…they’re all racing to integrate generative AI into their vast portfolios of products and features to ensure they don’t fall behind in a market that’s predicted to top $1 trillion in revenue within a decade.

It’s been full steam ahead, and a lot of investors have profited handsomely.

But has the race to dominate that $1 trillion market gotten ahead of itself?

Some analysts are saying yes — and they’re making some reasonable arguments to back them up…

The Case for a Cool Down

Let’s start with Goldman Sachs’ Senior Macro Strategist Allison Nathan. She recently released a client note suggesting the benefits gained from AI weren’t justifying its current costs.

The promise of generative AI technology to transform companies, industries, and societies continues to be touted, leading tech giants, other companies, and utilities to spend an estimated ~$1tn on capex in coming years, including significant investments in data centers, chips, other AI infrastructure, and the power grid. But this spending has little to show for it so far beyond reports of efficiency gains among developers.

Billion dollar solutions… that aren’t saving billions of dollars.

Analyst Brandon Smith…

There is no evidence of a single benefit to AI on a broader social scale. At most, it looks like it will be good at taking jobs away from web developers and McDonald’s drive-thru employees.

And the costs to train AI haven’t slowed.

Researchers at Epoch AI discovered the “cost of the computational power required to train the models is doubling every nine months.”

So has AI overpromised on its future?

In a word… No.

And should investors be concerned about these projections?

That’s a little more complicated. That answer comes in two parts.

Don’t Fade the “Bubble”

Back in the late 1990s, any tech company with even a remote connection to some aspect of the internet was being bought hand over fist. Regardless of whether or not they had produced dollar-one in revenue… or even had a viable business model!

It was the “new paradigm” of investing.

Everyone knows how that ended.

Today, the companies involved in the AI race are all trillion (or near-trillion) dollar companies. Nothing like the “wish and a hope” companies from the 90s.

That makes the AI rally more substantial.

So if you’re invested in AI-related firms and your shares are still headed higher…

Don’t fade the bubble.

It may be a bubble, but bubbles still make people a lot of money.

What’s important is to be aware that it is a bubble. What crushed everyone during the tech bust was the absolute certainty that “this time it’s different.”

It never is.

So that’s number one. The second point, and this is even more important, is to…

Understand the “Long Game”

AI has been a “thing” since the 1950s. But only recently has the technology to actually produce large scale AI applications become available.

That means the industry is just starting to evolve.

Some AI applications will undoubtedly tank. Others, however, that can prove their value will be adopted by the market. And those companies will see exponential growth.

This means that going forward you don’t want to think of AI in general terms. You want to consider it in terms of specific areas of application. Areas where serious ROI could actually be realized.

One area that comes to mind is the healthcare industry.

The healthcare system is plagued by massive inefficiencies: From skyrocketing administrative costs (thanks to a largely broken billing and payment system) to poor patient outcomes that are the result of fragmented treatment and care coordination.

Studies in the National Library of Medicine suggest that if the problems of uncoordinated care, redundant tests, and adverse drug events could be resolved it could save the industry as much as $240 billion.

Other estimates have been bigger:

According to research highlighted by Forbes, a quarter of US healthcare spending — almost $1 trillion — is wasted on inefficient or unnecessary patient care. Operational inefficiencies represent a tremendous opportunity for healthcare organizations to increase their retained earnings while bringing in the same revenue.

A number of huge players understand this and have started investing billions to stake claims in the industry.

One example is none other than Google Health. This division of Alphabet is actively developing AI solutions for medical imaging analysis and diagnostics, predictive modeling and health research.

Another player in the current healthcare market is global conglomerate GE Healthcare. They are now working with AI to develop not only diagnostics systems but also patient monitoring systems and hospital operations management tools.

Cerner Corporation (a subsidiary of Oracle) is developing models for clinical decision/pedictive support. They are also focusing on electronic health record (EHR) solutions, revenue cycle management and other operational efficiencies.

But these are all billion dollar companies (trillions in the case of Google) and returns based on their advances in healthcare AI would be tough to realize. To really get a bang for your investment buck, savvy investors should research solid, smaller-cap companies for whom a breakthrough in the market could be transformative.

Tim Collins, Senior Analyst at Streetlight Confidential, recently wrote about a company that fits that description — Healwell AI.

Healwell AI is a small Canadian company that has developed strategic partnerships with seven medical tech companies all working on AI solutions including:

• Solutions that will allow physicians to rapidly screen and identify patients with rare diseases to facilitate more personalized treatment.

• The development of state-of-the-art EMR or EHR (records management) solutions…

• AI technologies that enable earlier diagnosis and treatment and improved quality of life for the patient

• Applications to target patients that are eligible for specifically approved medications or interventions that can vastly improve patient outcomes…

They’ve also partnered with a leading contract research organization (CRO) specializing in Phase 1 and Phase 2a clinical trials. (Focusing on the field of pharmaceutical development.)

They also have access to one of the most important factors in AI training… data.

The company has partnered with Canada’s largest healthcare provider network, WELL Health, and has exclusive rights to its pool of patient data. WELL Health Technologies Corp. is the largest healthcare technology company in Canada.

All this gives them huge potential throughout the entire healthcare industry.

You can see Tim’s latest research on Healwell AI here.

The bottom line where AI goes is this…

The initial FOMO may be coming to an end. But it won’t be the end of AI.

There is simply too much potential in this technology for it to just fade away.

Instead of just counting on Nvidia to keep selling more and more chips, smart investors will have to start looking for areas where AI will actually pay off!

According to the Guinness book of world records, it’s the most fearless creature in the world.

A ferocious little critter (only about two feet long when you count their tails) that’s impervious to cobra venom, bee stings and just about every other threat that might be lurking in the African plains. (They’ll even throw down with a lion!)

They eat pretty much anything from lizards to rodents to snakes to birds and bee larvae.

We’re talking about the Mellivora Capensis… aka the Honey Badger.

And as the saying goes, “the honey badger don’t give a $#!%…”

Lately, one market has taken on a honey badger attitude.

In mid-September, the Fed decided it was time for rates to start coming down and they began a new easing cycle lowering their Fed Funds target rate by a full 50 basis points. (An aggressive move by any account!)

But like the honey badger, the bond market didn’t give a $#!%.

As the Fed started its easing cycle, yields on the 10-year note, the US’ borrowing benchmark, bottomed. And in the ensuing weeks they have actually risen from roughly 3.6% to nearly 4.25%!

US Treasury 10-Year Yield

What’s Going On?

The US has just closed out its 2024 fiscal year and the results, as expected, were abysmal.

According to Janet Yellen and the Treasury, the budget deficit hit its highest level in history. (That’s not counting the two outlier years during the pandemic stimmy giveaways.)

The total deficit for FY 2024 topped $1.8 trillion.

And while that’s bad enough on its own, in what might be the greatest irony in financial history, the largest contributor to that deficit was… interest on the debt.

If you scroll down the Treasury’s monthly statement it shows they paid out over $84 billion in interest payments in the last month of the fiscal year. That increased last year’s total interest expense by a staggering 29% to $1.13 trillion.

That was more than the government spent on Medicare and the defense budget.

Needless to say, the exploding interest cost is a serious problem.

When it comes to government debt, nothing gets retired. The Treasury simply rolls its debt over, refinancing the securities that come due. Which simply adds to the total amount of debt — increasing the interest expense they have to pay.

Now interest on the debt will soon become the biggest contributor to the debt itself.

Think about it. This year alone has added over $1 trillion to the annual base borrowing needs of the country. Before we pay for anything else. In that same 2024 fiscal year, the country took in $4.92 trillion in income. The interest cost ate up 23% of that.

This, of course, increases the amount of debt that has to be issued every year. And higher yields make that cost go up exponentially. (You don’t need to be a financial genius to know borrowing at 1% is better than 5%.)

This situation is one of the main (albeit unspoken) reasons the Fed is scrambling to lower rates — to ease the ever-expanding interest burden the spendthrifts in the government keep racking up.

The only problem with the Fed’s plan is that the funds rate is an overnight borrowing rate between banks that no longer have to maintain any reserve requirements.

So it’s basically just just for show.

It would appear the bond market (the folks who actually buy our debt and finance our deficits) knows this — and it doesn’t give a $#!%…

Election issues may be factoring into this rise in yields, but we don’t think it’s to any significant degree.

More likely the market may be reacting to what it knows is going to be an ever increasing supply of bonds they’re going to need to buy. (More supply = lower bond prices = higher bond yields.)

And this could easily force yields, as one Fed chairman once noted, to stay higher for longer. We’ll see as the week’s progress. But should the market take out previous yield highs of 5%, 6.5% could be within reach.

For now understand that when it comes to the Fed… the bond market don’t give a $#!%!

AI explosion creates monster investment opportunity

The government’s on a roll…

The Treasury Department just issued its Monthly Treasury Report and indicated that the government overspent by $296 billion in February.

So far this year they’ve shelled out $593 billion for social security, $369 billion on health care, $363 billion on defense, $350 billion in interest payments, $324 billion for Medicare and on and on it goes. All this deficit spending is finding its way into the economy (and adding to that net interest payment) and giving it the appearance of above average growth. (Perpetual debt isn’t growth… or at least it shouldn’t be.)

But last week the economy actually got some bona fide good news…

PMI is Back in the Headlines

We’ve talked about the Purchasing Managers Index and why it’s an underrated but important indicator.

First is because purchasing managers are in the know about nearly everything that’s going on in their companies.

The second reason is it’s an incredibly straightforward calculation. A net score above 50 is good. A net score below 50 indicates trouble.

The third reason is because it’s as close to a real time indicator that you can get. (It’s not subject to months of revisions like so many other indicators.)

And if you want to add a fourth, it’s a forward-looking indicator. It’s what purchasing managers see coming.

PMI reports (issued by the Institute for Supply Management (ISM) and S&P Global) are reported for both manufacturing and service businesses. Services, which have been the foundations of our economy for some time, had been keeping things afloat over the past couple years.

But in the most recent reports for March, manufacturing readings in both indexes rose back above 50.

And that’s a good sign for the sector.

A Boom in Manufacturing?

A boom in manufacturing would be an honest-to-goodness good thing for the economy.

According to the US census, manufacturing is the fifth largest employment sector in the economy…

The manufacturing sector is responsible for the largest dollar amount of exports in the US…

According to McKinsey:

The country currently meets 71 percent of its final demand with regional goods, trailing Germany (with 83 percent), Japan (86 percent), and China (89 percent).

manufacturing means greater supply chain resilience…

They’ve created a graphic that sums up all the benefits of a healthy manufacturing sector…

So this developmenet is actually osme pretty good news for the economy.

And if the trend persist…

Now Comes the Bad News

Stocks have long been anticipating the Fed to cut rates. Cheap money means “risk on.” And the market’s been risk on since at least November 2023. (If not October 2022.)

An actual boost in manufacturing PMI is probably the worst news they could get.

An actual growth spurt in the economy, one that has come with a funds rate of 5.5%, means easing should be out of the question. (PMI manufacturing prices paid dumped gas all over that fire jumping way above estimates as well.)

Higher for longer carries all kinds of risks for other parts of the financial system. The Treasury has trillions in maturing debt to refinance and regional banks are holding hundreds of billions of CRE debt their books that will need to be refinanced soon as well.

We’ve previously suggested a strategy the Fed might use in the future to justify cuts. It’s still on the table

Tomorrow, however, we’ll get more clarity when official inflation numbers come out.

Today’s investing landscape may be as difficult to navigate as it’s ever been.

This is in large part due to changes that have taken place over the past decades.

Two important distinctions investors should be aware of today.

First…

The Stock Market Is Not the Economy…

Not so long ago, when the US economy was a value-based engine, the stock market could be considered a decent measure of economic activity.

Manufacturing companies who produced and sold more products earned more money. And investors in those companies were rewarded with higher share prices and often dividend payouts.

Everyone’s a winner.

Today we no longer live in a traditional value-based economy. Sure, we have industries that produce stuff that’s sold here and around the world. But more and more that continues to change.

Today, and for the past roughly 50 years, the stock market has turned from a measure of an industrial economy into a tool of financial elites.

A means to make money from money. Period.

If you want the big picture, think of the golden age of the corporate raider — the time associated with the “Go-Go 80s” and personified by Gordon Gekko in the movie Wall Street.

The strategy back then was to acquire distressed manufacturing companies and drain whatever cash flow they could. Corporate raiders cut capital and operating expenditures and sold off assets. In the immortal words of Gekko himself, they’d wreck a company “because it’s wreckable!”

It wasn’t about investing to grow a company. It was about spending money for a fast return.

But the financialization wasn’t limited to the corporate vultures.

Manufacturing companies themselves even got in on the “make money from money” craze.

General Motors Acceptance Corporation and Ford Motor Credit were both established decades ago to finance car purchases. But during that same time they began to expand their interests into all sorts of other financial services including mortgages, insurance, banking and commercial finance.

Their financial efforts eventually began to eclipse their main businesses…

In 2004, GM reported that 66 percent of its $1.3 billion quarterly profits came from GMAC; while a day earlier, Ford reported a loss in its automotive operation but $1.17 billion in net income, mostly from its financing operation.

Today, stock buybacks are all the rage.

After a shaky start earlier this year, Apple announced it would buy back $110 billion of its shares. Without changing a thing in its operations, its share price suddenly exploded making them once again the most valuable company in the world.

Much of the stock market has become addicted to this financialization. And that’s why cheap capital (low interest rates) is so important.

This is an important fact to understand. Stock indexes do NOT represent the economy.

…And Neither Are Economic Reports

The second thing to understand is that “economic reports” don’t accurately represent the economy either.

Case in point.

GDP for the second quarter was just revised upwards to 3% — over doubling the first quarter’s report of 1.4% growth.

If you believe these numbers, business should be booming.

Yet in the first half of this year, corporate bankruptcies are soaring.

According to the June S&P Global Market Intelligence report: “The 346 total filings so far in 2024 is also higher than any comparable figure in the prior 13 years.”

Personal consumption expenditures (the fancy name for consumer spending) rose 0.7% in the second quarter as well. But sales numbers for many consumer-facing companies like General Mills…

MINNEAPOLIS – General Mills (NYSE: NYSE:GIS) has confirmed its financial targets for fiscal year 2025, expecting organic net sales to be flat to up 1 percent, and an adjusted operating profit ranging from a 2 percent decline to flat in constant currency.

…Hershey…

The stock of iconic US chocolate maker Hershey tumbled after the company slashed its sales and earnings outlook for the year as shoppers continue to reduce purchases of higher priced chocolates and candies.

Q2 sales plunged 17% to $2.07 billion, sharply missing the $2.31 billion estimate. Adjusted EPS of $1.27 per share also missed expectations.

…even dollar stores…

Shares of Dollar Tree plunged nearly 12% in premarket trading in New York after the discount retailer, which operates thousands of stores nationwide, posted fiscal second-quarter earnings that fell short of Wall Street expectations. The company also slashed its full-year outlook, pointing to mounting financial pressures on middle-income and higher-income customers. This comes less than a week after major rival Dollar General reported a “financially constrained core customer” that sent shares crashing the most on record.

…have been struggling as well.

And then there are all the jobs that have been added to the economy…

Today, given all the potential for revisions and seasonal adjustments, economic reports really don’t mean much where the future of a stock — or even an entire index — goes.

Heck, they don’t even accurately represent the economy.

These financial and economic “dislocations” can create havoc for investors.

But we make them our business here, to make sure our readers are the best-informed investors they can be.